Vascular endothelial growth factor and transforming growth factor β in hypertrophic adenoids in children suffering

Beata Zelazowska-Rutkowska1, Bozena Skotnicka2, Bogdan Cylwik1

  • 1Department of Pediatric Laboratory Diagnostics, Medical University of Bialystok, Poland.

Cytokine
|May 22, 2020
PubMed

Insights

Elevated vascular endothelial growth factor A (VEGF-A) and transforming growth factor beta (TGF-β) indicate bacterial pathogens in children with adenoid hypertrophy and otitis media. These cytokines can aid in diagnosing exudative otitis media.

Area of Science:

  • Pediatric Otolaryngology
  • Immunology
  • Biochemistry

Background:

  • Adenoid hypertrophy is common in children.
  • Exudative otitis media (OME) often co-occurs with adenoid hypertrophy.
  • Cytokine profiles in adenoid tissue may offer diagnostic insights.

Purpose of the Study:

  • To compare levels of VEGF-A and TGF-β in children with adenoid hypertrophy and OME versus those with only adenoid hypertrophy.
  • To evaluate the diagnostic potential of VEGF-A and TGF-β in OME.

Main Methods:

  • Adenoid tissues were collected from children with OME and adenoid hypertrophy (study group) and children with only adenoid hypertrophy (reference group).
  • VEGF-A and TGF-β levels were measured in stimulated adenoid cell cultures using ELISA.
  • ROC analysis was performed to assess diagnostic accuracy.

Main Results:

  • VEGF-A and TGF-β concentrations were significantly higher in the OME group compared to the reference group.
  • VEGF-A demonstrated high diagnostic accuracy (AUC 0.952, 95% sensitivity and specificity).
  • TGF-β also showed good diagnostic potential (AUC 0.902, 60% sensitivity, 95% specificity).

Conclusions:

  • Increased VEGF-A and TGF-β levels suggest a role for bacterial pathogens in pediatric OME.
  • VEGF-A and TGF-β measurements can serve as objective biomarkers for diagnosing OME in children.
  • These cytokines may help confirm clinical diagnoses of exudative otitis media.
Abstract

Related Concept Videos

Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
3.2K
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
10.2K
Role of Hematopoietic Growth Factors01:28

Role of Hematopoietic Growth Factors

Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
3.0K
Pulmonary Hypertension: Classification and Pathogenesis01:30

Pulmonary Hypertension: Classification and Pathogenesis

Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
485
Hormonal Regulation of Blood Pressure01:17

Hormonal Regulation of Blood Pressure

Endocrinal or hormonal intervention in the cardiovascular system is predominantly exerted by the catecholamines - epinephrine and norepinephrine, as well as a slew of hormones that interact with renal function to modulate blood volume.
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction...
5.6K
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
577